{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:45:34Z","timestamp":1791081934748,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,1]],"date-time":"2027-04-01T00:00:00Z","timestamp":1806537600000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P50 AR054626"],"award-info":[{"award-number":["P50 AR054626"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000183","name":"US Army Research Office","doi-asserted-by":"publisher","award":["W911NF-21-1-0248"],"award-info":[{"award-number":["W911NF-21-1-0248"]}],"id":[{"id":"10.13039\/100000183","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY010804"],"award-info":[{"award-number":["R01EY010804"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["MDA 964119"],"award-info":[{"award-number":["MDA 964119"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006827","name":"Florida Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ymthe.2025.12.041","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T08:06:45Z","timestamp":1766563605000},"page":"2119-2133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Transient muscle expression of mitoARCUS in mice leads to sustained reductions in pathogenic mtDNA and reduces fatigability"],"prefix":"10.1016","volume":"34","author":[{"given":"Sandra R.","family":"Bacman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Shoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Spencer","family":"Henley-Beasley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhese","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Domingo","family":"Barrera-Paez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise-Michelle","family":"Theard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Rodriguez-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Gorsuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth R.","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8077-7092","authenticated-orcid":false,"given":"Carlos T.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.12.041_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14061287","article-title":"Gene Therapy for Mitochondrial Diseases: Current Status and Future Perspective","volume":"14","author":"Di Donfrancesco","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ymthe.2025.12.041_bib2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cell.2020.02.051","article-title":"Mitochondrial Diseases: Hope for the Future","volume":"181","author":"Russell","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.12.041_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/978-981-13-8367-0_14","article-title":"Heteroplasmy Shifting as Therapy for Mitochondrial Disorders","volume":"1158","author":"Naeem","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ymthe.2025.12.041_bib4","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201949612","article-title":"Mitochondrial DNA heteroplasmy in disease and targeted nuclease-based therapeutic approaches","volume":"21","author":"Nissanka","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ymthe.2025.12.041_bib5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1042\/bj20021594","article-title":"Mitochondrial threshold effects","volume":"370","author":"Rossignol","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymthe.2025.12.041_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.80","article-title":"Mitochondrial diseases","volume":"2","author":"Gorman","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2025.12.041_bib7","doi-asserted-by":"crossref","first-page":"R92","DOI":"10.1093\/hmg\/ddae037","article-title":"Tools for editing the mammalian mitochondrial genome","volume":"33","author":"Moraes","year":"2024","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.12.041_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102132","article-title":"mitoTALEN reduces the mutant mtDNA load in neurons","volume":"35","author":"Bacman","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ymthe.2025.12.041_bib9","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/s41591-018-0166-8","article-title":"MitoTALEN reduces mutant mtDNA load and restores tRNA(Ala) levels in a mouse model of heteroplasmic mtDNA mutation","volume":"24","author":"Bacman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.12.041_bib10","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/s44321-025-00231-5","article-title":"Clinically translatable mitochondrial gene therapy in muscle using tandem mtZFN architecture","volume":"17","author":"Nash","year":"2025","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.12.041_bib11","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/s41591-018-0165-9","article-title":"Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo","volume":"24","author":"Gammage","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.12.041_bib12","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1038\/s41467-021-23561-7","article-title":"Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo","volume":"12","author":"Zekonyte","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.12.041_bib13","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/s42255-023-00932-6","article-title":"Efficient elimination of MELAS-associated m.3243G mutant mitochondrial DNA by an engineered mitoARCUS nuclease","volume":"5","author":"Shoop","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ymthe.2025.12.041_bib14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41586-020-2477-4","article-title":"A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing","volume":"583","author":"Mok","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.041_bib15","article-title":"Enhanced C-To-T and A-To-G Base Editing in Mitochondrial DNA with Engineered DdCBE and TALED","volume":"11","author":"Wei","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ymthe.2025.12.041_bib16","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.1038\/s41467-022-34784-7","article-title":"Compact zinc finger base editors that edit mitochondrial or nuclear DNA in vitro and in vivo","volume":"13","author":"Willis","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.12.041_bib17","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.cell.2022.03.039","article-title":"Targeted A-to-G base editing in human mitochondrial DNA with programmable deaminases","volume":"185","author":"Cho","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.12.041_bib18","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41587-023-01791-y","article-title":"Strand-selective base editing of human mitochondrial DNA using mitoBEs","volume":"42","author":"Yi","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2025.12.041_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/protein\/gzq083","article-title":"The I-CreI meganuclease and its engineered derivatives: applications from cell modification to gene therapy","volume":"24","author":"Arnould","year":"2011","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.ymthe.2025.12.041_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1472-6750-12-86","article-title":"Targeted DNA excision in Arabidopsis by a re-engineered homing endonuclease","volume":"12","author":"Antunes","year":"2012","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.ymthe.2025.12.041_bib21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2025.12.041_bib22","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ymthe.2023.01.010","article-title":"Binding and neutralizing anti-AAV antibodies: Detection and implications for rAAV-mediated gene therapy","volume":"31","author":"Schulz","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.041_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.12.041_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102129","article-title":"Delivery of RNAs to Specific Organs by Lipid Nanoparticles for Gene Therapy","volume":"14","author":"Godbout","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ymthe.2025.12.041_bib25","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1038\/s41467-021-26714-w","article-title":"Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice","volume":"12","author":"Kenjo","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.12.041_bib26","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1016\/j.celrep.2016.08.037","article-title":"A Phenotype-Driven Approach to Generate Mouse Models with Pathogenic mtDNA Mutations Causing Mitochondrial Disease","volume":"16","author":"Kauppila","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2025.12.041_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fragi.2025.1585508","article-title":"Preclinical models of mitochondrial dysfunction: mtDNA and nuclear-encoded regulators in diverse pathologies","volume":"6","author":"Miller","year":"2025","journal-title":"Front. Aging"},{"key":"10.1016\/j.ymthe.2025.12.041_bib28","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41586-024-08469-8","article-title":"Precise modelling of mitochondrial diseases using optimized mitoBEs","volume":"639","author":"Zhang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.041_bib29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymthe.2025.12.041_bib30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41541-023-00751-6","article-title":"Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability","volume":"8","author":"Zhang","year":"2023","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2025.12.041_bib31","doi-asserted-by":"crossref","first-page":"33058","DOI":"10.1021\/acsnano.4c08490","article-title":"Distinct Inflammatory Programs Underlie the Intramuscular Lipid Nanoparticle Response","volume":"18","author":"Dowell","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2025.12.041_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41541-024-00900-5","article-title":"Distinct dynamics of mRNA LNPs in mice and nonhuman primates revealed by in vivo imaging","volume":"9","author":"Lemdani","year":"2024","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2025.12.041_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adr0792","article-title":"Correcting a pathogenic mitochondrial DNA mutation by base editing in mice","volume":"17","author":"Barrera-Paez","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2025.12.041_bib34","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1038\/s41467-018-04895-1","article-title":"The mitochondrial DNA polymerase gamma degrades linear DNA fragments precluding the formation of deletions","volume":"9","author":"Nissanka","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.12.041_bib35","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/s41467-018-04131-w","article-title":"Linear mitochondrial DNA is rapidly degraded by components of the replication machinery","volume":"9","author":"Peeva","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.12.041_bib36","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1101\/gr.227202","article-title":"Pattern of organization of human mitochondrial pseudogenes in the nuclear genome","volume":"12","author":"Woischnik","year":"2002","journal-title":"Genome Res."},{"key":"10.1016\/j.ymthe.2025.12.041_bib37","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1038\/s41467-022-29989-9","article-title":"Targeting double-strand break indel byproducts with secondary guide RNAs improves Cas9 HDR-mediated genome editing efficiencies","volume":"13","author":"Bodai","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.12.041_bib38","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ymthe.2004.05.004","article-title":"A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs","volume":"10","author":"Hagstrom","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.041_bib39","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.omtm.2017.10.005","article-title":"DNA-Mediated Gene Therapy in a Mouse Model of Limb Girdle Muscular Dystrophy 2B","volume":"7","author":"Ma","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.12.041_bib40","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/mus.24714","article-title":"Functional in situ assessment of muscle contraction in wild-type and mdx mice","volume":"53","author":"Tamayo","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2025.12.041_bib41","doi-asserted-by":"crossref","first-page":"14392","DOI":"10.1073\/pnas.0502896102","article-title":"Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease","volume":"102","author":"Bayona-Bafaluy","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.12.041_bib42","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1021\/acs.molpharmaceut.1c00916","article-title":"Lipid-Nanoparticle-Based Delivery of CRISPR\/Cas9 Genome-Editing Components","volume":"19","author":"Kazemian","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ymthe.2025.12.041_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2024.101922","article-title":"Beyond the membrane: Exploring non-viral methods for mitochondrial gene delivery","volume":"78","author":"Singh","year":"2024","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ymthe.2025.12.041_bib44","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/pharmaceutics15020572","article-title":"Delivery Systems for Mitochondrial Gene Therapy: A Review","volume":"15","author":"Faria","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ymthe.2025.12.041_bib45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.molmed.2023.02.004","article-title":"Brain gene therapy with Trojan horse lipid nanoparticles","volume":"29","author":"Pardridge","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymthe.2025.12.041_bib46","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.3390\/pharmaceutics13101675","article-title":"Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery","volume":"13","author":"Zak","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ymthe.2025.12.041_bib47","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.12.041_bib48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11095-022-03166-5","article-title":"Biodistribution and Non-linear Gene Expression of mRNA LNPs Affected by Delivery Route and Particle Size","volume":"39","author":"Di","year":"2022","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ymthe.2025.12.041_bib49","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.celrep.2018.02.014","article-title":"A Single Administration of CRISPR\/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing","volume":"22","author":"Finn","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2025.12.041_bib50","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.122.062132","article-title":"Efficacy and Safety of an Investigational Single-Course CRISPR Base-Editing Therapy Targeting PCSK9 in Nonhuman Primate and Mouse Models","volume":"147","author":"Lee","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ymthe.2025.12.041_bib51","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","article-title":"In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates","volume":"593","author":"Musunuru","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.12.041_bib52","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1016\/j.ymthe.2022.05.013","article-title":"Targeting the hepatitis B cccDNA with a sequence-specific ARCUS nuclease to eliminate hepatitis B virus in vivo","volume":"30","author":"Gorsuch","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.041_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/cells10020206","article-title":"COVID-19: Characteristics and Therapeutics","volume":"10","author":"Chilamakuri","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2025.12.041_bib54","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2309472120","article-title":"Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects","volume":"120","author":"Chen","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2025.12.041_bib55","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s13023-022-02538-9","article-title":"Pearson syndrome: a multisystem mitochondrial disease with bone marrow failure","volume":"17","author":"Yoshimi","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymthe.2025.12.041_bib56","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/01.bor.0000245729.17759.f2","article-title":"Mitochondrial myopathies","volume":"18","author":"DiMauro","year":"2006","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.ymthe.2025.12.041_bib57","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3389\/fcell.2019.00305","article-title":"Characterization of Factors Involved in Localized Translation Near Mitochondria by Ribosome-Proximity Labeling","volume":"7","author":"Vardi-Oknin","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2025.12.041_bib58","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cell.2010.02.026","article-title":"Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations","volume":"141","author":"Chen","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.12.041_bib59","first-page":"394","article-title":"Mitochondrial transfer and implications for muscle function in idiopathic inflammatory myopathies","volume":"42","author":"Gonzalez Chapa","year":"2024","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.ymthe.2025.12.041_bib60","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.1093133","article-title":"Nanotubular highways for intercellular organelle transport","volume":"303","author":"Rustom","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.12.041_bib61","doi-asserted-by":"crossref","first-page":"C862","DOI":"10.1152\/ajpcell.00212.2023","article-title":"Muscle mitochondrial transplantation can rescue and maintain cellular homeostasis","volume":"325","author":"Bhattacharya","year":"2023","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ymthe.2025.12.041_bib62","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/STROKEAHA.108.516153","article-title":"Effect of simultaneous botulinum toxin injections into several muscles on impairment, activity, participation, and quality of life among stroke patients presenting with a stiff knee gait","volume":"39","author":"Caty","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.ymthe.2025.12.041_bib63","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ymthe.2024.12.032","article-title":"Low-inflammatory lipid nanoparticle-based mRNA vaccine elicits protective immunity against H5N1 influenza virus with reduced adverse reactions","volume":"33","author":"Kawai","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.12.041_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9050530","article-title":"Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety","volume":"9","author":"Vlatkovic","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ymthe.2025.12.041_bib65","series-title":"Rationally-designed meganucleases with altered sequence specificity and DNA-binding affinity","author":"Smith","year":"2013"},{"key":"10.1016\/j.ymthe.2025.12.041_bib66","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/laban0511-155","article-title":"Retro-orbital injections in mice","volume":"40","author":"Yardeni","year":"2011","journal-title":"Lab Anim."},{"key":"10.1016\/j.ymthe.2025.12.041_bib67","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1089\/hum.2009.133","article-title":"Functional efficacy of dystrophin expression from plasmids delivered to mdx mice by hydrodynamic limb vein injection","volume":"21","author":"Zhang","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2025.12.041_bib68","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/gt.2010.25","article-title":"Organ-specific shifts in mtDNA heteroplasmy following systemic delivery of a mitochondria-targeted restriction endonuclease","volume":"17","author":"Bacman","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymthe.2025.12.041_bib69","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/nm.3261","article-title":"Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs","volume":"19","author":"Bacman","year":"2013","journal-title":"Nat. Med."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625010640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001625010640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:47:39Z","timestamp":1778816859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001625010640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1525001625010640"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.12.041","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transient muscle expression of mitoARCUS in mice leads to sustained reductions in pathogenic mtDNA and reduces fatigability","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.12.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}